FT Julphar MENA Biotechnology & Biosimilars Forum
FT Julphar MENA Biotechnology and Biosimilars Forum
Creating a World Class Biotechnology Industry in MENA
9 December 2013 | The Address Downtown, Dubai

The Financial Times and Julphar would like to thank all of the speakers and delegates that participated in the FT Julphar MENA Biotechnology and Biosimilars Forum for making this innaugural gathering of industry experts, investors, policy makers and regulators from across the region and internationally such a success.

With the growing affluence of their citizens, the increasing relevance of lifestyle diseases and the expansion of the healthcare infrastructure, the countries of the MENA region represent a significant opportunity for life science companies.  
This one day conference discussed the emerging opportunities and challenges facing the biotechnology sector in the MENA.

Speakers Included:

Christopher Hansung Ko
Chief Executive Officer
Samsung Bioepis

Amin Hussain Al Amiri
Undersecretary for Medical Practice and License
UAE Ministry of Health

Marie-Christine Bielsky
Senior Medical Assessor, Biologicals and Biotechnology Unit, Licensing Division
Medicines and Healthcare Products Regulatory Agency, UK (MHRA)

Tawfik Khoja
Director General
Health Ministers Council for Cooperation, SGH

Ayman Sahli
Chief Executive Officer
Julphar-Gulf Pharmaceutical Industries

Thomas Lönngren
Strategic Adviser
NDA Regulatory Science;
Former Executive Director
European Medicines Agency (EMA)

Chaired By:

Andrew Jack
Pharmaceuticals Correspondent
Financial Times

Forum Preview Video:

Under the Patronage of:
H.H. Sheikh Maktoum Bin Mohammed Bin Rashid Al Maktoum, Deputy Ruler of Dubai


Post Event Media:

Attendees of the event can access the presentations here by entering the password provided to them by email.

Photos from the event can be found on Flickr.